Wuhan's virus is not the same as the current version

Coronavirus, whom the World Health Organization calls the world's number one enemy, is not the same virus that appeared in China at the end of 2019. Sars-Cov-2, as it was officially appointed, has so far killed more than 600,000 people in the world and continues on the road to destruction has mutated. While scientists in [...]
Sars-Cov-2, as it was officially appointed, has so far killed more than 600,000 people in the world and continues on the road to destruction has mutated.
While scientists around the world are recording changes in the genetic code of the virus, only one of them has so far been isolated, perhaps changing behavior, the BBC writes.
The mutation virus is reported to have registered 97 percent of samples worldwide and has a higher transmission power than the original laboratory version.
There are questions related to this mutation - whether the virus is more contagious or deadly in humans and if it poses a threat to the success of a future vaccine that has not yet been created.
The only important mutation, called D614G, emerged sometime after the outbreak began in Wuhan, probably in Italy, and is now recorded at 97 percent of the world's samples.
It is still not known whether this prevalence of mutation is sufficient to give the virus any advantage or if it is accidental.
“Virus constantly mutate and while some changes will help the virus multiply, some may prevent it. Others are just neutral. They are a side effect of virus reproduction. They stop the virus so they don't change his behavior,” says Lucy van Dorp from college in London.
The mutation of the virus spread after it occurred at an early stage of the spread of the coronary, and this phenomenon is known as the founder's <x0).
Van Dorp and her associates believe that this is the most likely explanation of why mutation is so widespread.
Tusan De Silva from Sheffield University in Great Britain says that a growing number of virologists believe there is enough data that the actual version of the virus has a subtle, evolutionary advantage over the early virus.
He explains that although there is not yet sufficient evidence to say that it is easier to pass on to people, it is certainly not neutral.
The researchers in the laboratory have shown that the mutation virus is introduced into human cells more easily than the original version, say Professors Hjerijin Choe and Michael Farzan from Scrips University in Florida, adding that protein changes seem to be used by the virus to improve human cells better and functioned more efficiently.
Professor Farzan claims that the proteins of these viruses are different in a way that suggests that they be transmitted better but cannot be tested.
Nevile Sanyana from the Genome Technology Centre at New York University, which works on genetic modification technology, went a step further, and her team reprocessed the virus by making protein changes and then facing the Sars virus- CoV2 from the original focus on Wuhan on human tissue cells.
Sanyana believes the result showed that the mutation virus has a higher transmission power than the original version, at least in laboratory conditions.
There is indirect evidence that mutations make the coronary the most transmitted to humans, and two studies show that patients with a version of the coronary that had mutated, have higher amounts of the virus in samples taken for testing, which may suggest they are more contagious to others.
However, there was no evidence that such ones had more severe symptoms than those who stayed in the hospital. The fact that the virus has become more transmitted is said to have not meant that it has become more deadly and has not yet been tested.
D614G variation It's so prevalent that it's now a pandemic. This has been the case for some time, perhaps even since the beginning of the pandemic in Great Britain or even in the area of the eastern US coast, scientists claim.
Also, writes BBC, this study should not have an impact on the development of the vaccine and its effects, and it adds that there is evidence that the current virus is sensitive to antibodies, which can protect us from re-influence.











